Shanghai Chest Hospital
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- -
- Established
- 1957-01-01
- Employees
- -
- Market Cap
- -
Combination Therapy of Sintilimab and Anlotinib as a First-line Treatment in Advanced NSCLC (SUNRISE)
Phase 2
- Conditions
- Interventions
- First Posted Date
- 2019-10-11
- Last Posted Date
- 2019-10-11
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 98
- Registration Number
- NCT04124731
ENB Guided MWA for Early-stage Peripheral Lung Cancer
- First Posted Date
- 2019-07-02
- Last Posted Date
- 2020-01-10
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT04005157
- Locations
- 🇨🇳
Shanghai Chest Hospital, Shanghai, Shanghai, China
China Lung Cancer Screening (CLUS) Study Version 2.0
Not Applicable
- Conditions
- Interventions
- First Posted Date
- 2019-06-05
- Last Posted Date
- 2022-06-01
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 6000
- Registration Number
- NCT03975504
- Locations
- 🇨🇳
Shanghai Chest hospital, Shanghai, Shanghai, China
Pre-Surgery If Needed for Oesophageal Cancer
- First Posted Date
- 2019-05-03
- Last Posted Date
- 2019-08-12
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 400
- Registration Number
- NCT03937362
- Locations
- 🇨🇳
Chang Gung Memorial Hospital, Linkou, Taiwan
🇨🇳Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
🇨🇳Shanghai Chest Hospital, Shanghai, China
KN046 in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma
Phase 2
- Conditions
- Interventions
- First Posted Date
- 2019-04-25
- Last Posted Date
- 2019-05-29
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT03927495
- Locations
- 🇨🇳
The First Affiliated Hospital of Suzhou University, Suzhou, China
Apatinib in the Treatment of Recurrence or Metastasis of Esophageal Cancer
Phase 2
- Conditions
- Interventions
- First Posted Date
- 2019-04-12
- Last Posted Date
- 2020-02-05
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 39
- Registration Number
- NCT03913182
- Locations
- 🇨🇳
Shanghai Chest Hospital, Shanghai, Shanghai, China
Electromagnetic Navigation Versus CT Guided TTNA in the Diagnosis of Early Peripheral Lung Cancer
Not Applicable
- Conditions
- Interventions
- First Posted Date
- 2019-01-14
- Last Posted Date
- 2019-01-14
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 322
- Registration Number
- NCT03802266
- Locations
- 🇨🇳
Shanghai Chest hospital, Shanghai, Shanghai, China
ENB for the Diagnosis of PPNs:a Real World Study
Completed
- Conditions
- First Posted Date
- 2018-10-23
- Last Posted Date
- 2022-08-03
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 479
- Registration Number
- NCT03716284
- Locations
- 🇨🇳
Shanghai Chest Hospital, Shanghai, Shanghai, China
Non-Invasive ctDNA Methylation Detection for Lung Nodule Patients
- Conditions
- First Posted Date
- 2018-09-26
- Last Posted Date
- 2019-01-23
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 300
- Registration Number
- NCT03685669
- Locations
- 🇨🇳
Shanghai Chest Hospital, Shanghai, Shanghai, China
First-line Combination Treatment Based on Anlotinib
Phase 1
- Conditions
- Interventions
- First Posted Date
- 2018-08-14
- Last Posted Date
- 2018-08-14
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 80
- Registration Number
- NCT03628521
- Locations
- 🇨🇳
Shanghai Chest Hospital, Shanghai, Shanghai, China
© Copyright 2024. All Rights Reserved by MedPath